Oct 05, 2016
Dr. Stephen Eck, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council, talks about the importance of personalized therapies for cancer. “Historically, we’ve tried to develop therapies that are good for the average patient. When none of us are all that average,” Dr. Eck on the weaknesses of traditional approaches to treating cancer.
“Understanding those differences will allow patients to have therapies that are more effective with fewer side effects,” Dr. Stephen Eck on the hope of Personalized Therapies.
Dr. Stephen Eck is Vice President and Global Head of Oncology Medical Sciences at Astellas Pharma Global Development. He is responsible for designing, implementing and interpreting novel clinical trials for new medicines that he hopes to bring to cancer patients.